Dr. Cobert is US board certified in Internal Medicine and Gastroenterology. He graduated from the New York University School of Medicine with an MD and trained there in Medicine and Gastroenterology. He did a subsequent Hepatology post-doc at the Hôpital Beaujon/INSERM (Clichy, France). He was in practice at NYU-Bellevue Hospital before joining the pharmaceutical industry. He is a fellow of the American College of Physicians, the American College of Gastroenterology and the Faculty of Pharmaceutical Physicians. He is licensed in 3 states and on the staff at the NYU School of Medicine and Rutgers.
He has worked at Ives Laboratories (now Wyeth), Hoechst-Roussel Pharmaceuticals (now Sanofi-Aventis), Schering-Plough (now Merck), Novartis Consumer Health, Forest Laboratories and Becton Dickinson. He was head of global drug safety at Schering Plough from 1993 until his retirement in 2004. He also headed the global drug safety group at Novartis Consumer Health and has a decade of experience in clinical research (running phase II, III, IV studies).
From 1989 to 2004 he served on various International Conference on Harmonisation (ICH) working groups, co-chairing one, representing PhRMA covering GCP, E2B and PSURs. He is on the Editorial Board of the journal Expert Opinion in Drug Safety.
He has written five textbooks (two with Prof. Pierre Biron and one with Dr. Mike Klepper) on Drug Safety including Cobert's Manual of Drug Safety and Pharmacovigilance 2nd edition published by Jones & Bartlett in 2011. It is used as the textbook in various drug safety courses. He has multiple publications in refereed journals. With his wife, Dr. Josiane Cobert, he has written a book for the public on childhood obesity.
Dr. Cobert has been an invited speaker at many courses and conferences including DIA, the European Society of Pharmacovigilance, the WHO Anniversary Symposium on Pharmacovigilance, PERI, the University of Montréal, Tufts University, Brigham & Women's Hospital, Temple University, the Journées Annuelles de Santé Publique (Quebec), Chinese Food & Drug Administration (SFDA) Training Session in Clinical Research (Sanya, China), Pharmacovigilance University and elsewhere.
He has experience in drug safety software development both at Schering Plough and at Medidata Solutions Inc.
In addition to 30 years in drug safety and pharmacovigilance, Dr. Cobert has senior level experience in drug safety crisis management, interactions with FDA & other health authorities, organizational re-engineering, training, compliance/quality, GCP, risk management and drug safety software development.
He is a dual US & French citizen.